The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|March 2, 2022
- Pharmaceutical Technology, March 2022 Issue
- Volume 46
- Issue 3
- Pages: 12
Lyophilized Master Mix
Author(s)Pharmaceutical Technology Editors
New England Biolabs Luna Probe One-Step RT-qPCR Mix with UDG enables sensitive, linear, real-time detection of target RNA sequences.
New England Biolabs (NEB) Luna Probe One-Step RT- quantitative polymerase chain reaction (qPCR) Mix with uracil-DNA glycosylase (UDG) enables sensitive, linear, real-time detection of target RNA sequences in a room temperature-stable format. When measured in NEB’s “dot in boxes” scoring method—a high-throughput data visualization tool that provides quality scores for qPCR outcomes—the LyoPrime Luna outperformed many competitor products and strongly matched the company’s liquid mix, according to the company.
The lyophilized mix contains murine RNase Inhibitor, deoxynucleoside triphosphate, and a passive reference dye. It incorporates thermolabile UDG, which is well-suited to RNA workflows, as well as deoxyuridine triphosphate to reduce carryover contamination risk between reactions.
Articles in this issue
over 4 years ago
The Shape of Dosage Formsover 4 years ago
Successfully Accelerating Formulation Strategiesover 4 years ago
Process Performance as a Means of Quality Managementover 4 years ago
The State of Phage Therapyover 4 years ago
Troubleshooting Using Predictive Maintenanceover 4 years ago
A New Route to Pharma GDP Compliance and Standardizationover 4 years ago
Empowering Protein Characterizationover 4 years ago
Cold Comfort for Bio/Pharmaover 4 years ago
Selecting and Optimizing the Right Manufacturing Partnerover 4 years ago
Standing in SolidarityRelated to this article
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
How to test pen injector assembly interfaces from URS to FAT and SAT: verify part tracking, reject confirmation, restarts, and data transfer evidence.
Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.